Back to Browse Journals » Pathology and Laboratory Medicine International » Volume 3

Fibrous dysplasia of bone: a clinicopathologic review

Authors Mohan H, Mittal P, Mundi I, Kumar S

Published 8 November 2011 Volume 2011:3 Pages 31—42

DOI http://dx.doi.org/10.2147/PLMI.S24866

Review by Single-blind

Peer reviewer comments 3

Harsh Mohan1, Preeti Mittal1, Irneet Mundi1, Sudhir Kumar2
1Department of Pathology, 2Department of Orthopedics, Government Medical College, Sector 32, Chandigarh, India

Abstract: Fibrous dysplasia of the bones is an uncommon congenital skeletal disorder that is found equally in both genders and is not inherited. Its etiology has been linked to an activating mutation of Gsα and the downstream effects of the resultant increase in cAMP. Fibrous dysplasia is categorized as either monostotic or polyostotic, and may occur as a component of McCune-Albright syndrome or the rare Mazabraud syndrome. Long bones, skull bones, and ribs are the most commonly affected bones. The radiological picture is somewhat variable, including a ground-glass appearance, expansion of the bone, and sclerosis surrounding the lesion. Histologically, fibrous dysplasia shows irregularly-shaped trabeculae of immature, woven bone in a background of variably cellular, loosely arranged fibrous stroma. It may be complicated by pathologic fracture, and rarely by malignant transformation. This review examines interesting issues surrounding the etiology of fibrous dysplasia, its clinical and laboratory manifestations, radiological picture, utility of bone biopsy, gross and microscopic pathology, complications, and its differential diagnostic considerations.

Keywords: fibrous dysplasia, McCune-Albright syndrome, monostotic form, polyostotic form

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Progress toward curing HIV infection with hematopoietic cell transplantation

Petz LD, Burnett JC, Li HT, Li S, Tonai R, Bakalinskaya M, Shpall EJ, Armitage S, Kurtzberg J, Regan DM, Clark P, Querol S, Gutman JA, Spellman SR, Gragert L, Rossi JJ

Stem Cells and Cloning: Advances and Applications 2015, 8:109-116

Published Date: 28 July 2015

DNA ploidy of cervical epithelial cells should be a cure criterion of high-risk HPV infection in Xinjiang Uygur women

Feng YC, Yang J, Liu CM, Cheng ZZ, Huang YC

OncoTargets and Therapy 2015, 8:827-833

Published Date: 13 April 2015

Surgical therapies for corneal perforations: 10 years of cases in a tertiary referral hospital

Yokogawa H, Kobayashi A, Yamazaki N, Masaki T, Sugiyama K

Clinical Ophthalmology 2014, 8:2165-2170

Published Date: 29 October 2014

Is increasing the dose of Entecavir effective in partial virological responders?

Erturk A, Adnan Akdogan R, Parlak E, Cure E, Cumhur Cure M, Ozturk C

Drug Design, Development and Therapy 2014, 8:621-625

Published Date: 29 May 2014

Role of pharmacogenomics in the treatment of tuberculosis: a review

Ramachandran G, Swaminathan S

Pharmacogenomics and Personalized Medicine 2012, 5:89-98

Published Date: 13 September 2012

Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future

Sinha R, Nastoupil LJ, Flowers CR

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:87-98

Published Date: 19 April 2012

Assessment of the efficacy of first-line antimalarial drugs after 5 years of deployment by the National Malaria Control Programme in Côte d'Ivoire

Offianan AT, Assi SB, Coulibaly A, N'guessan LT, Ako AA, Kadjo FK, San MK, Penali LK

Open Access Journal of Clinical Trials 2011, 3:67-76

Published Date: 11 November 2011

Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution

Mösges R, Nematian-Samani M, Eichel A

Therapeutics and Clinical Risk Management 2011, 7:325-326

Published Date: 27 July 2011